Aurigene Oncology announces phase 1 results for India’s first CAR-T cell therapy in multiple Myeloma
SWASTH study reports clinical response in all patients; Drugs Controller General of India approves Phase 2 trial
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.